Tamtam Try Tamtam free
Radboudumc logo

Radboudumc account plan

Medical education patient care

At a glance

Radboudumc is the university medical centre of Nijmegen, one of eight Dutch UMCs: €1,619.8m 2025 revenue, 12,702 employees.

Radboudumc (Stichting Radboud universitair medisch centrum) is the university medical centre of Nijmegen and one of the eight Dutch university medical centres, providing mostly highly complex, top-referral patient care alongside medical education and research; Radboud University's medical faculty is part of it. In 2025 it treated 219,010 unique patients, with 485,464 outpatient consultations and 30,918 operations. Consolidated revenue was €1,619.8m in 2025 (2024: €1,534.6m) and the net result €32.8m, with an EBITDA margin of 7.90%. It had 12,702 employees, an average of 8,964 FTE. Funding comes mainly from health insurers, government availability payments and Ministry of Education grants.

Business units

Strategic priorities

Dealing with scarcity
For 2026 the main focus is scarcity of people and resources: reducing care demand, portfolio choices, shifting care to regional hospitals and appropriate care, plus capacity management and staff retention and recruitment.
Financial resilience
The board decided to lift the EBITDA margin to at least 8% within three years and raised its internal solvency norm to 30% for 2026, expecting financial tightening rather than easing.
Leading role in AI and medical technology
A Data & AI Table was installed in 2025 and a comprehensive Data & AI strategy across care, research and education is under development, aligned with the European Health Data Space.
Focused research portfolio
Research programmes will be merged, dissolved or supported to maturity, and five will be designated top programmes for six years; action plans are due by October 2026.
Advanced therapies
Radboudumc backs more pharmaceutical and advanced-therapy development, as most launched products so far are MedTech; a central cleanroom for advanced therapies is due end 2026.

Investments and deals

Masterplan Bouw
The building masterplan runs to 2030 and is being re-baselined to a 2050 horizon, with a new masterplan and business case expected end 2027; 2025 tangible capex was €95.3m.
Clinical infrastructure projects
A new central sterilisation and scope disinfection unit (Q2 2026), patient-care laboratories in building F (mid-2026), renovation of the east-flank care buildings and planning for Radiotherapy building G.
Cleanroom for advanced therapies
A central cleanroom for advanced therapies due end 2026, supporting the push into pharmaceutical and advanced-therapy development.
AI in the electronic health record
An Augmented Response Technology pilot in Epic ran with 4 departments, with a second round planned for 5 more in 2026.

Challenges and risks

Funding cuts
The board expects cuts to education and research funding and substantial healthcare cuts to fund rising defence spending.
Staff shortages
Radboudumc had 770 vacancies at the end of 2025 and absenteeism of 5.56%; sufficient qualified staff is a named strategic risk.
Cybersecurity and regulation
Several intrusion attempts were recorded in 2025, none disruptive; preparation for the Cyberbeveiligingswet, NIS2 and the EU AI Act is underway.
Geopolitics and prices
Geopolitical tension and trade barriers affecting prices are named risks; the crisis plan was updated, including the reception of military casualties.

What leadership says

“They are not corrective; they are invitations to keep improving. That is exactly the culture we want: not being satisfied with the status quo.”

Guillén Fernández, Scientific Director, Research Institute for Medical Innovation · Interview on the SEP evaluation 2018-2024, Radboudumc website

“This evaluation report is reassuring, but the real work starts now.”

Guillén Fernández, Scientific Director, Research Institute for Medical Innovation · Interview on the SEP evaluation 2018-2024, Radboudumc website

Where a supplier can help

Workforce and capacity tools
With scarcity the main 2026 focus and 770 vacancies, capacity management, scheduling, recruitment and staff-retention offers tie directly to a stated priority.
Data, AI and Epic integration
The Data & AI strategy, the Augmented Response Technology pilot in Epic and FAIR data work create room for clinical AI, data stewardship and integration partners.
Building and clinical equipment
Masterplan Bouw renovations, the new sterilisation unit and the advanced-therapy cleanroom open opportunities for construction, equipment and cleanroom suppliers.
Cybersecurity compliance
Preparation for NIS2 and the Cyberbeveiligingswet, after several intrusion attempts in 2025, points to security services and compliance tooling.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Radboudumc?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Radboudumc

What does Radboudumc do?

Radboudumc is the university medical centre of Nijmegen, providing highly complex top-referral patient care, medical education and research, organised in 11 patient-care centres and three institutes.

What is Radboudumc's revenue?

Consolidated revenue was €1,619.8m in 2025, up from €1,534.6m in 2024, with a net result of €32.8m.

How many employees does Radboudumc have?

Radboudumc had 12,702 employees in 2025, an average of 8,964 FTE.

Who leads Radboudumc?

The Executive Board is chaired by Bertine Lahuis, with Jan Smit as vice-chair and dean, Lot Winkel as CFO and Frédérique van Berkestijn as COO.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)